View Item 

Show simple item record

Organ Donation and Utilization in the United States: 1998–2007

dc.contributor.authorTuttle-Newhall, J. E.en_US
dc.contributor.authorKrishnan, S. M.en_US
dc.contributor.authorLevy, M. F.en_US
dc.contributor.authorMcBride, V.en_US
dc.contributor.authorOrlowski, J. P.en_US
dc.contributor.authorSung, Randall S.en_US
dc.date.accessioned2010-06-01T20:23:36Z
dc.date.available2010-06-01T20:23:36Z
dc.date.issued2009-04en_US
dc.identifier.citationTuttle-Newhall, J. E.; Krishnan, S. M.; Levy, M. F.; McBride, V.; Orlowski, J. P.; Sung, R. S. (2009). "Organ Donation and Utilization in the United States: 1998–2007." American Journal of Transplantation 9(4p2 The 2008 SRTR Report on the State of Transplantation ): 879-893. <http://hdl.handle.net/2027.42/73508>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73508
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19341413&dopt=citationen_US
dc.format.extent175678 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2009 American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherDeceased Donor Organsen_US
dc.subject.otherDonationen_US
dc.subject.otherLiving Donor Transplantationen_US
dc.subject.otherOrgan Utilizationen_US
dc.subject.otherSRTR/OPTNen_US
dc.titleOrgan Donation and Utilization in the United States: 1998–2007en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherDuke University Health System, Durham, NCen_US
dc.contributor.affiliationotherKidney Epidemiology and Cost Center, Ann Arbor, MIen_US
dc.contributor.affiliationotherScientific Registry of Transplant Recipients, Ann Arbor, MIen_US
dc.contributor.affiliationotherBaylor All Saints Medical Center, Fort Worth, TXen_US
dc.contributor.affiliationotherDepartment of Health and Human Services, Health Resources and Services Administration, Rockville, MDen_US
dc.contributor.affiliationotherCenter for Donation and Transplant, Albany, NYen_US
dc.identifier.pmid19341413en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73508/1/j.1600-6143.2009.02565.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2009.02565.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreference1.  Collaborative management team. TGMC measurement strategies, Available from: http://www.healthdisparities.net, 2007.en_US
dc.identifier.citedreference2.  Available from: http://www.unos.org/CommitteeReports/board_main_OperationsCommittee_6_12_2006_14_20.pdfen_US
dc.identifier.citedreference3.  Available from: http://www.UNOS.org: News release, 12 /6/2006, United network of organ sharing receives funding to continue developing a disease transmission data reporting system.en_US
dc.identifier.citedreferenceTaylor G. Donornet at 18 months: What can and does it tell us. Available from: OPTN UNOS Data Presentation at AOPA November, 2008.en_US
dc.identifier.citedreference5.  Available from: http://www.optn.org/CommitteeReports/board_main_TransplantAdministratorsCommittee_6_23_2008_16_47.pdfen_US
dc.identifier.citedreference6.  Personal correspondence South Carolina Organ Procurement Agency, Carolina Donor services, and Tennessee Donor Services, Accessed May 2008.en_US
dc.identifier.citedreferenceO'Connor K, Bradley JW, Sussman L, Luskin R, Delmonico F. Utilization of expedited liver placement and impact on the numbers of livers transplanted. AJT 2006; 273 ( Suppl 2 ):en_US
dc.identifier.citedreferenceSung RS, Galloway J, Tuttle-Newhall JE et al. Organ donation and utilization in the United States, 1997–2006. Am J Transplant 2008; 8: 922 – 934.en_US
dc.identifier.citedreference9.  Available from: Final analysis for data requests from the OPTN organ availability committee meeting of January 27, 2006.en_US
dc.identifier.citedreferenceSung RS, Christensen LL, Leichtman AB et al. Determinants of discard of expanded criteria donor kidneys: Impact of biopsy and machine perfusion. Am J Transplant 2008; 8: 783 – 792.en_US
dc.identifier.citedreferenceMoers C, Smits JM, Maathuis MJ et al. Transplantation after hypothermic machine perfusion versus static cold storage of deceased donor kidneys: A prospective randomized controlled trial. Am J Transplant (abstract) 2008; 8 ( Suppl 2 ): 225.en_US
dc.identifier.citedreferenceWight J, Chilcott J, Holmes M, Brewer N. The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. Health Technol Assess 2003; 7: 1 – 94.en_US
dc.identifier.citedreferenceAgarwal A, Murdock P, Fridell JA. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006; 81: 480 – 482.en_US
dc.identifier.citedreferenceLynch RJ, Kubus J, Chenault RH, Pelletier SJ, Campbell DA, Englesbe MJ. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant 2008; 8: 567 – 573.en_US
dc.identifier.citedreferenceEnglesbe MJ, Heidt D, Sung RS, Pietroski R. Does using HTK solution for cold perfusion of cadaveric kidneys save money? (letter ) Transplantation 2006; 81: 1750.en_US
dc.identifier.citedreferencePotdar S, Malek S, Eghtesad B et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18: 661 – 665.en_US
dc.identifier.citedreferenceEnglesbe MJ, Moyer A, Kim DY et al. Early pancreas transplant outcomes with HTK preservation: A multi-center study. Transplantation 2006; 82: 136 – 139.en_US
dc.identifier.citedreferenceFridell JA, Agarwal A, Milgrom ML, Goggins WC, Murdock P, Pescovitz MD. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77: 1304.en_US
dc.identifier.citedreferenceMangus RS, Tector AJ, Agarwal A, Vianna R, Murdock P, Fridell JA. Comparison of histidine-tryptophan-ketoglutarate solution and university of wisconsin solution in adult liver transplantation. Liver Transpl 2008; 12: 226 – 230.en_US
dc.identifier.citedreferenceMangus RS, Fridell JA, Vianna RM et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl 2008; 14: 365 – 373.en_US
dc.identifier.citedreference21.  Final analysis for data request from the pancreas outcomes model review sub-committee of the OPTN Pancreas Transplantation Committee.en_US
dc.identifier.citedreference22.  Final analysis for data requests from the OPTN Organ Availability Committee Meeting of March 3, 2006.en_US
dc.identifier.citedreferenceStewart ZA, Cameron AM, Singer AL, Dagher NN, Montgoemery RA, Segev DL. Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2008; 8: 217 – 221.en_US
dc.identifier.citedreferenceStewart ZA, Cameron AM, Singer AL, Dagher NN, Montgoemery RA, Segev DL. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2008; 8: Available from: ( online: http://www3.interscience.wiley.com/cgi-bin/fulltext/121545487/HTMLSTART ).en_US
dc.identifier.citedreferenceDoshi MD, Hunsicker LG. Short- and long-term outcomes with the use of kidney and livers donated after cardiac death. Am J Transplant 2007; 7: 122 – 129.en_US
dc.identifier.citedreferenceSung RS, Christensen LL, Ashby VB, Port FK, Merion RM, Leichtman AB. The evolution of donation after cardiac death (DCD) use and outcomes. Am J Transplant 2007; 7 ( Suppl 2 ): 308 (abstract).en_US
dc.identifier.citedreferenceLocke JE, Segev DL, Warren, DS, Dominici F, Simpkins CE, Montgomery RA. Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation. Am J Transplant 2007; 7: 1797 – 1807.en_US
dc.identifier.citedreferenceMerion RM, Pelletier SJ, Goodrich NP, Englesbe MJ, Delmonico FL. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006; 244: 555 – 562.en_US
dc.identifier.citedreferenceChan EY, Olson LC, Kisthard JA et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2006; 14: 604 – 610.en_US
dc.identifier.citedreferenceRenz JF. Is DCD for liver transplantation DNR? Am J Transplant 2008; 8: 485 – 488.en_US
dc.identifier.citedreference31.  Federal Register. May 2006; 71: 104, pp 30982 – 31054.en_US
dc.identifier.citedreference32.  42 CFR part 486.318.en_US
dc.identifier.citedreferenceDenham CR. The quality choir from warm-up to harmony. J Patient Safety 2005; 1: 170 – 176.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2009.02565.x.pdf
Size:
171.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.